Crossmark

Percutaneous direct pancreatic duct intervention in management of pancreatic fistulas: a primary treatment or temporizing therapy to prepare for elective surgery

Crossref DOI link: https://doi.org/10.1186/s12876-021-01620-z

Published Online: 2021-01-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Xi

Paz-Fumagalli, Ricardo https://orcid.org/0000-0002-9006-116X
Wang, Weiping

Toskich, Beau B.

Stauffer, John A.

Frey, Gregory T.

McKinney, J. Mark

Nguyen, Justin H.
Funding

Funding for this research was provided by:

China Scholarship Council (201806580017)
License Information

Text and Data Mining valid from 2021-01-28

Version of Record valid from 2021-01-28
More Information

Article History

Received: 19 July 2020

Accepted: 18 January 2021

First Online: 28 January 2021

Ethics approval and consent to participate

: Institutional Review Board approval, Mayo Clinic. Need for participation consent waived.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below